nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—ESR2—brain cancer	0.239	0.56	CbGaD
Tamoxifen—CYP2C9—brain cancer	0.188	0.44	CbGaD
Tamoxifen—CYP1B1—Procarbazine—brain cancer	0.154	0.436	CbGbCtD
Tamoxifen—CYP2D6—Lomustine—brain cancer	0.0212	0.0599	CbGbCtD
Tamoxifen—CYP1A2—Carmustine—brain cancer	0.021	0.0593	CbGbCtD
Tamoxifen—ABCC2—Carboplatin—brain cancer	0.0199	0.0562	CbGbCtD
Tamoxifen—ABCG2—Carboplatin—brain cancer	0.018	0.0508	CbGbCtD
Tamoxifen—ABCC2—Etoposide—brain cancer	0.0167	0.0471	CbGbCtD
Tamoxifen—CYP2D6—Hydroxyurea—brain cancer	0.0161	0.0454	CbGbCtD
Tamoxifen—CYP3A4—Temozolomide—brain cancer	0.0159	0.0448	CbGbCtD
Tamoxifen—ABCG2—Etoposide—brain cancer	0.0151	0.0426	CbGbCtD
Tamoxifen—CYP3A4—Lomustine—brain cancer	0.0135	0.0381	CbGbCtD
Tamoxifen—CYP2E1—Etoposide—brain cancer	0.0108	0.0304	CbGbCtD
Tamoxifen—CYP3A5—Etoposide—brain cancer	0.00836	0.0236	CbGbCtD
Tamoxifen—CYP2C8—Etoposide—brain cancer	0.00803	0.0227	CbGbCtD
Tamoxifen—CYP1A2—Etoposide—brain cancer	0.00622	0.0176	CbGbCtD
Tamoxifen—ABCB1—Etoposide—brain cancer	0.00544	0.0154	CbGbCtD
Tamoxifen—CYP3A4—Etoposide—brain cancer	0.00326	0.00921	CbGbCtD
Tamoxifen—SULT1A1—telencephalon—brain cancer	0.000947	0.0226	CbGeAlD
Tamoxifen—ESR2—hindbrain—brain cancer	0.000782	0.0187	CbGeAlD
Tamoxifen—SULT1A1—pituitary gland—brain cancer	0.000771	0.0184	CbGeAlD
Tamoxifen—EBPL—endocrine gland—brain cancer	0.000752	0.018	CbGeAlD
Tamoxifen—EBPL—head—brain cancer	0.000742	0.0177	CbGeAlD
Tamoxifen—EBP—endocrine gland—brain cancer	0.000721	0.0172	CbGeAlD
Tamoxifen—Diethylstilbestrol—ESR2—brain cancer	0.000691	0.275	CrCbGaD
Tamoxifen—EBPL—central nervous system—brain cancer	0.000677	0.0162	CbGeAlD
Tamoxifen—DHCR7—telencephalon—brain cancer	0.000673	0.0161	CbGeAlD
Tamoxifen—SULT1A1—spinal cord—brain cancer	0.000663	0.0159	CbGeAlD
Tamoxifen—EBPL—cerebellum—brain cancer	0.000662	0.0158	CbGeAlD
Tamoxifen—SULT1A1—endocrine gland—brain cancer	0.000597	0.0143	CbGeAlD
Tamoxifen—SULT1A1—head—brain cancer	0.00059	0.0141	CbGeAlD
Tamoxifen—DHCR7—gonad—brain cancer	0.000562	0.0134	CbGeAlD
Tamoxifen—ESR1—blood vessel—brain cancer	0.000562	0.0134	CbGeAlD
Tamoxifen—DHCR7—pituitary gland—brain cancer	0.000548	0.0131	CbGeAlD
Tamoxifen—FMO1—pituitary gland—brain cancer	0.000548	0.0131	CbGeAlD
Tamoxifen—Diethylstilbestrol—CYP2C9—brain cancer	0.000542	0.216	CrCbGaD
Tamoxifen—ESRRA—pituitary gland—brain cancer	0.00054	0.0129	CbGeAlD
Tamoxifen—SULT1A1—central nervous system—brain cancer	0.000538	0.0129	CbGeAlD
Tamoxifen—EBPL—brain—brain cancer	0.000538	0.0129	CbGeAlD
Tamoxifen—ESR1—hindbrain—brain cancer	0.000536	0.0128	CbGeAlD
Tamoxifen—DHCR7—medulla oblongata—brain cancer	0.000529	0.0126	CbGeAlD
Tamoxifen—Ospemifene—CYP2C9—brain cancer	0.000528	0.21	CrCbGaD
Tamoxifen—SULT1A1—cerebellum—brain cancer	0.000526	0.0126	CbGeAlD
Tamoxifen—UGT1A4—endocrine gland—brain cancer	0.000521	0.0125	CbGeAlD
Tamoxifen—ESRRA—medulla oblongata—brain cancer	0.000521	0.0124	CbGeAlD
Tamoxifen—DHCR7—midbrain—brain cancer	0.000484	0.0116	CbGeAlD
Tamoxifen—ESRRA—midbrain—brain cancer	0.000476	0.0114	CbGeAlD
Tamoxifen—FMO3—pituitary gland—brain cancer	0.000474	0.0113	CbGeAlD
Tamoxifen—DHCR7—spinal cord—brain cancer	0.000472	0.0113	CbGeAlD
Tamoxifen—ESRRA—spinal cord—brain cancer	0.000464	0.0111	CbGeAlD
Tamoxifen—ESR2—brainstem—brain cancer	0.000448	0.0107	CbGeAlD
Tamoxifen—SULT1A1—brain—brain cancer	0.000427	0.0102	CbGeAlD
Tamoxifen—DHCR7—endocrine gland—brain cancer	0.000425	0.0102	CbGeAlD
Tamoxifen—FMO1—endocrine gland—brain cancer	0.000425	0.0102	CbGeAlD
Tamoxifen—DHCR7—head—brain cancer	0.000419	0.01	CbGeAlD
Tamoxifen—FMO1—head—brain cancer	0.000419	0.01	CbGeAlD
Tamoxifen—ESRRA—endocrine gland—brain cancer	0.000418	0.00999	CbGeAlD
Tamoxifen—ESRRA—head—brain cancer	0.000413	0.00987	CbGeAlD
Tamoxifen—ESR2—telencephalon—brain cancer	0.000398	0.00951	CbGeAlD
Tamoxifen—DHCR7—central nervous system—brain cancer	0.000383	0.00915	CbGeAlD
Tamoxifen—FMO1—central nervous system—brain cancer	0.000383	0.00915	CbGeAlD
Tamoxifen—ESRRA—central nervous system—brain cancer	0.000377	0.00901	CbGeAlD
Tamoxifen—DHCR7—cerebellum—brain cancer	0.000374	0.00894	CbGeAlD
Tamoxifen—ABCB11—endocrine gland—brain cancer	0.000371	0.00887	CbGeAlD
Tamoxifen—ESRRA—cerebellum—brain cancer	0.000368	0.0088	CbGeAlD
Tamoxifen—FMO3—endocrine gland—brain cancer	0.000367	0.00877	CbGeAlD
Tamoxifen—CYP3A7—endocrine gland—brain cancer	0.000363	0.00868	CbGeAlD
Tamoxifen—FMO3—head—brain cancer	0.000362	0.00866	CbGeAlD
Tamoxifen—Sensory loss—Etoposide—brain cancer	0.000336	0.00318	CcSEcCtD
Tamoxifen—Infection—Lomustine—brain cancer	0.000336	0.00318	CcSEcCtD
Tamoxifen—ESR2—gonad—brain cancer	0.000332	0.00794	CbGeAlD
Tamoxifen—Cardiovascular disorder—Etoposide—brain cancer	0.000331	0.00314	CcSEcCtD
Tamoxifen—Thrombocytopenia—Lomustine—brain cancer	0.000331	0.00313	CcSEcCtD
Tamoxifen—FMO3—central nervous system—brain cancer	0.000331	0.00791	CbGeAlD
Tamoxifen—Pain—Carboplatin—brain cancer	0.000331	0.00313	CcSEcCtD
Tamoxifen—Neoplasm—Temozolomide—brain cancer	0.000329	0.00311	CcSEcCtD
Tamoxifen—Sepsis—Carmustine—brain cancer	0.000327	0.00309	CcSEcCtD
Tamoxifen—ESR2—pituitary gland—brain cancer	0.000324	0.00774	CbGeAlD
Tamoxifen—Sweating—Procarbazine—brain cancer	0.000323	0.00306	CcSEcCtD
Tamoxifen—Anorexia—Lomustine—brain cancer	0.000322	0.00305	CcSEcCtD
Tamoxifen—Blood creatinine increased—Hydroxyurea—brain cancer	0.000317	0.003	CcSEcCtD
Tamoxifen—Swelling—Carmustine—brain cancer	0.00031	0.00293	CcSEcCtD
Tamoxifen—SIGMAR1—telencephalon—brain cancer	0.000308	0.00737	CbGeAlD
Tamoxifen—ESR1—brainstem—brain cancer	0.000307	0.00734	CbGeAlD
Tamoxifen—FMO1—brain—brain cancer	0.000304	0.00726	CbGeAlD
Tamoxifen—DHCR7—brain—brain cancer	0.000304	0.00726	CbGeAlD
Tamoxifen—Haemoglobin—Procarbazine—brain cancer	0.000304	0.00288	CcSEcCtD
Tamoxifen—Haemorrhage—Procarbazine—brain cancer	0.000302	0.00286	CcSEcCtD
Tamoxifen—Inflammation—Etoposide—brain cancer	0.0003	0.00284	CcSEcCtD
Tamoxifen—ESRRA—brain—brain cancer	0.000299	0.00715	CbGeAlD
Tamoxifen—Injury—Carmustine—brain cancer	0.000297	0.00282	CcSEcCtD
Tamoxifen—CYP2D6—hindbrain—brain cancer	0.000294	0.00703	CbGeAlD
Tamoxifen—Decreased appetite—Lomustine—brain cancer	0.000294	0.00278	CcSEcCtD
Tamoxifen—Hepatic failure—Temozolomide—brain cancer	0.000294	0.00278	CcSEcCtD
Tamoxifen—CYP1B1—telencephalon—brain cancer	0.000293	0.00701	CbGeAlD
Tamoxifen—CES1—endocrine gland—brain cancer	0.00029	0.00693	CbGeAlD
Tamoxifen—Pancreatitis—Hydroxyurea—brain cancer	0.000287	0.00271	CcSEcCtD
Tamoxifen—CES1—head—brain cancer	0.000286	0.00684	CbGeAlD
Tamoxifen—Hot flush—Temozolomide—brain cancer	0.000282	0.00267	CcSEcCtD
Tamoxifen—Flushing—Procarbazine—brain cancer	0.000281	0.00266	CcSEcCtD
Tamoxifen—Menopausal symptoms—Temozolomide—brain cancer	0.00028	0.00265	CcSEcCtD
Tamoxifen—Skin exfoliation—Etoposide—brain cancer	0.000278	0.00263	CcSEcCtD
Tamoxifen—Thirst—Temozolomide—brain cancer	0.000278	0.00263	CcSEcCtD
Tamoxifen—Pancytopenia—Hydroxyurea—brain cancer	0.000278	0.00263	CcSEcCtD
Tamoxifen—Neutropenia—Hydroxyurea—brain cancer	0.000273	0.00259	CcSEcCtD
Tamoxifen—ESR1—telencephalon—brain cancer	0.000273	0.00651	CbGeAlD
Tamoxifen—Arrhythmia—Procarbazine—brain cancer	0.00027	0.00256	CcSEcCtD
Tamoxifen—Alopecia—Procarbazine—brain cancer	0.000267	0.00253	CcSEcCtD
Tamoxifen—Weight increased—Hydroxyurea—brain cancer	0.000266	0.00252	CcSEcCtD
Tamoxifen—FMO3—brain—brain cancer	0.000263	0.00628	CbGeAlD
Tamoxifen—CYP19A1—gonad—brain cancer	0.000262	0.00625	CbGeAlD
Tamoxifen—CES1—central nervous system—brain cancer	0.000261	0.00624	CbGeAlD
Tamoxifen—Sepsis—Etoposide—brain cancer	0.000253	0.00239	CcSEcCtD
Tamoxifen—Liver function test abnormal—Carmustine—brain cancer	0.000252	0.00239	CcSEcCtD
Tamoxifen—Dextropropoxyphene—CYP2C9—brain cancer	0.000251	0.1	CrCbGaD
Tamoxifen—SIGMAR1—pituitary gland—brain cancer	0.000251	0.006	CbGeAlD
Tamoxifen—ESR2—endocrine gland—brain cancer	0.000251	0.006	CbGeAlD
Tamoxifen—Mood swings—Temozolomide—brain cancer	0.00025	0.00237	CcSEcCtD
Tamoxifen—ESR2—head—brain cancer	0.000248	0.00592	CbGeAlD
Tamoxifen—CYP1B1—gonad—brain cancer	0.000245	0.00585	CbGeAlD
Tamoxifen—Anaemia—Procarbazine—brain cancer	0.000243	0.0023	CcSEcCtD
Tamoxifen—SIGMAR1—medulla oblongata—brain cancer	0.000242	0.00579	CbGeAlD
Tamoxifen—Swelling—Etoposide—brain cancer	0.00024	0.00227	CcSEcCtD
Tamoxifen—CYP1B1—pituitary gland—brain cancer	0.000239	0.0057	CbGeAlD
Tamoxifen—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000238	0.00225	CcSEcCtD
Tamoxifen—Dysphagia—Carmustine—brain cancer	0.000236	0.00224	CcSEcCtD
Tamoxifen—Leukopenia—Procarbazine—brain cancer	0.000236	0.00223	CcSEcCtD
Tamoxifen—Haemoglobin—Hydroxyurea—brain cancer	0.000235	0.00223	CcSEcCtD
Tamoxifen—Haemorrhage—Hydroxyurea—brain cancer	0.000234	0.00221	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000233	0.00221	CcSEcCtD
Tamoxifen—Cough—Procarbazine—brain cancer	0.00023	0.00217	CcSEcCtD
Tamoxifen—Dysphagia—Temozolomide—brain cancer	0.000228	0.00216	CcSEcCtD
Tamoxifen—ESR1—gonad—brain cancer	0.000227	0.00544	CbGeAlD
Tamoxifen—Hypertension—Procarbazine—brain cancer	0.000227	0.00215	CcSEcCtD
Tamoxifen—ESR2—central nervous system—brain cancer	0.000226	0.0054	CbGeAlD
Tamoxifen—Pancytopenia—Carmustine—brain cancer	0.000224	0.00212	CcSEcCtD
Tamoxifen—Arthralgia—Procarbazine—brain cancer	0.000224	0.00212	CcSEcCtD
Tamoxifen—Myalgia—Procarbazine—brain cancer	0.000224	0.00212	CcSEcCtD
Tamoxifen—Anxiety—Procarbazine—brain cancer	0.000223	0.00211	CcSEcCtD
Tamoxifen—CYP2A6—cerebellum—brain cancer	0.000222	0.00531	CbGeAlD
Tamoxifen—ESR1—pituitary gland—brain cancer	0.000222	0.0053	CbGeAlD
Tamoxifen—ABCB1—blood vessel—brain cancer	0.000222	0.0053	CbGeAlD
Tamoxifen—SIGMAR1—midbrain—brain cancer	0.000221	0.00529	CbGeAlD
Tamoxifen—ESR2—cerebellum—brain cancer	0.000221	0.00528	CbGeAlD
Tamoxifen—Neutropenia—Carmustine—brain cancer	0.000221	0.00209	CcSEcCtD
Tamoxifen—Bronchitis—Temozolomide—brain cancer	0.00022	0.00208	CcSEcCtD
Tamoxifen—Dry mouth—Procarbazine—brain cancer	0.000219	0.00207	CcSEcCtD
Tamoxifen—ABCG2—telencephalon—brain cancer	0.000218	0.00522	CbGeAlD
Tamoxifen—Pancytopenia—Temozolomide—brain cancer	0.000217	0.00205	CcSEcCtD
Tamoxifen—SIGMAR1—spinal cord—brain cancer	0.000216	0.00516	CbGeAlD
Tamoxifen—Vomiting—Lomustine—brain cancer	0.000215	0.00204	CcSEcCtD
Tamoxifen—Oedema—Procarbazine—brain cancer	0.000215	0.00203	CcSEcCtD
Tamoxifen—Neutropenia—Temozolomide—brain cancer	0.000213	0.00202	CcSEcCtD
Tamoxifen—Infection—Procarbazine—brain cancer	0.000213	0.00202	CcSEcCtD
Tamoxifen—Pneumonia—Carmustine—brain cancer	0.000212	0.00201	CcSEcCtD
Tamoxifen—Erectile dysfunction—Temozolomide—brain cancer	0.00021	0.00199	CcSEcCtD
Tamoxifen—Thrombocytopenia—Procarbazine—brain cancer	0.00021	0.00199	CcSEcCtD
Tamoxifen—Depression—Carmustine—brain cancer	0.00021	0.00199	CcSEcCtD
Tamoxifen—Weight increased—Temozolomide—brain cancer	0.000208	0.00197	CcSEcCtD
Tamoxifen—Hyperhidrosis—Procarbazine—brain cancer	0.000208	0.00197	CcSEcCtD
Tamoxifen—CES1—brain—brain cancer	0.000207	0.00496	CbGeAlD
Tamoxifen—Alopecia—Hydroxyurea—brain cancer	0.000207	0.00196	CcSEcCtD
Tamoxifen—Weight decreased—Temozolomide—brain cancer	0.000207	0.00196	CcSEcCtD
Tamoxifen—Urinary tract infection—Carmustine—brain cancer	0.000205	0.00194	CcSEcCtD
Tamoxifen—Pneumonia—Temozolomide—brain cancer	0.000205	0.00194	CcSEcCtD
Tamoxifen—Anorexia—Procarbazine—brain cancer	0.000205	0.00194	CcSEcCtD
Tamoxifen—Erythema—Hydroxyurea—brain cancer	0.000204	0.00193	CcSEcCtD
Tamoxifen—Depression—Temozolomide—brain cancer	0.000203	0.00192	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000202	0.00191	CcSEcCtD
Tamoxifen—Nausea—Lomustine—brain cancer	0.000201	0.0019	CcSEcCtD
Tamoxifen—Urinary tract infection—Temozolomide—brain cancer	0.000198	0.00187	CcSEcCtD
Tamoxifen—CYP19A1—endocrine gland—brain cancer	0.000198	0.00473	CbGeAlD
Tamoxifen—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000196	0.00185	CcSEcCtD
Tamoxifen—CYP19A1—head—brain cancer	0.000195	0.00467	CbGeAlD
Tamoxifen—Insomnia—Procarbazine—brain cancer	0.000194	0.00184	CcSEcCtD
Tamoxifen—Paraesthesia—Procarbazine—brain cancer	0.000193	0.00183	CcSEcCtD
Tamoxifen—Sinusitis—Temozolomide—brain cancer	0.000191	0.00181	CcSEcCtD
Tamoxifen—Cramp muscle—Etoposide—brain cancer	0.00019	0.0018	CcSEcCtD
Tamoxifen—Haemoglobin—Carmustine—brain cancer	0.00019	0.0018	CcSEcCtD
Tamoxifen—Haemorrhage—Carmustine—brain cancer	0.000189	0.00179	CcSEcCtD
Tamoxifen—CYP2E1—telencephalon—brain cancer	0.000189	0.00452	CbGeAlD
Tamoxifen—ABCC2—endocrine gland—brain cancer	0.000189	0.00451	CbGeAlD
Tamoxifen—Anaemia—Hydroxyurea—brain cancer	0.000188	0.00178	CcSEcCtD
Tamoxifen—Hypoaesthesia—Carmustine—brain cancer	0.000188	0.00178	CcSEcCtD
Tamoxifen—Decreased appetite—Procarbazine—brain cancer	0.000187	0.00177	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Etoposide—brain cancer	0.000186	0.00176	CcSEcCtD
Tamoxifen—Oedema peripheral—Carmustine—brain cancer	0.000186	0.00176	CcSEcCtD
Tamoxifen—Fatigue—Procarbazine—brain cancer	0.000185	0.00175	CcSEcCtD
Tamoxifen—CYP1B1—endocrine gland—brain cancer	0.000185	0.00442	CbGeAlD
Tamoxifen—Haemoglobin—Temozolomide—brain cancer	0.000184	0.00174	CcSEcCtD
Tamoxifen—Constipation—Procarbazine—brain cancer	0.000184	0.00174	CcSEcCtD
Tamoxifen—Pain—Procarbazine—brain cancer	0.000184	0.00174	CcSEcCtD
Tamoxifen—CYP2C8—pituitary gland—brain cancer	0.000183	0.00437	CbGeAlD
Tamoxifen—Haemorrhage—Temozolomide—brain cancer	0.000183	0.00173	CcSEcCtD
Tamoxifen—Hepatitis—Temozolomide—brain cancer	0.000183	0.00173	CcSEcCtD
Tamoxifen—Dysphagia—Etoposide—brain cancer	0.000183	0.00173	CcSEcCtD
Tamoxifen—CYP1B1—head—brain cancer	0.000183	0.00436	CbGeAlD
Tamoxifen—Leukopenia—Hydroxyurea—brain cancer	0.000182	0.00173	CcSEcCtD
Tamoxifen—Visual impairment—Carmustine—brain cancer	0.000182	0.00173	CcSEcCtD
Tamoxifen—Hypoaesthesia—Temozolomide—brain cancer	0.000182	0.00172	CcSEcCtD
Tamoxifen—Pharyngitis—Temozolomide—brain cancer	0.000181	0.00172	CcSEcCtD
Tamoxifen—CYP2A6—brain—brain cancer	0.00018	0.00431	CbGeAlD
Tamoxifen—Oedema peripheral—Temozolomide—brain cancer	0.00018	0.0017	CcSEcCtD
Tamoxifen—ESR2—brain—brain cancer	0.00018	0.00429	CbGeAlD
Tamoxifen—CYP19A1—central nervous system—brain cancer	0.000178	0.00426	CbGeAlD
Tamoxifen—ABCG2—pituitary gland—brain cancer	0.000178	0.00425	CbGeAlD
Tamoxifen—Diphenhydramine—CYP2C9—brain cancer	0.000176	0.0703	CrCbGaD
Tamoxifen—Visual impairment—Temozolomide—brain cancer	0.000176	0.00167	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Procarbazine—brain cancer	0.000176	0.00166	CcSEcCtD
Tamoxifen—Flushing—Carmustine—brain cancer	0.000175	0.00166	CcSEcCtD
Tamoxifen—Pancytopenia—Etoposide—brain cancer	0.000173	0.00164	CcSEcCtD
Tamoxifen—Erythema multiforme—Temozolomide—brain cancer	0.000173	0.00164	CcSEcCtD
Tamoxifen—ESR1—endocrine gland—brain cancer	0.000172	0.00411	CbGeAlD
Tamoxifen—ABCG2—medulla oblongata—brain cancer	0.000172	0.0041	CbGeAlD
Tamoxifen—Discomfort—Hydroxyurea—brain cancer	0.000171	0.00162	CcSEcCtD
Tamoxifen—SIGMAR1—cerebellum—brain cancer	0.000171	0.00409	CbGeAlD
Tamoxifen—Neutropenia—Etoposide—brain cancer	0.000171	0.00162	CcSEcCtD
Tamoxifen—Urticaria—Procarbazine—brain cancer	0.000171	0.00161	CcSEcCtD
Tamoxifen—Methadone—CYP2C9—brain cancer	0.00017	0.0678	CrCbGaD
Tamoxifen—Abdominal pain—Procarbazine—brain cancer	0.00017	0.00161	CcSEcCtD
Tamoxifen—ESR1—head—brain cancer	0.00017	0.00406	CbGeAlD
Tamoxifen—Flushing—Temozolomide—brain cancer	0.00017	0.00161	CcSEcCtD
Tamoxifen—Arrhythmia—Carmustine—brain cancer	0.000169	0.0016	CcSEcCtD
Tamoxifen—CYP2D6—brainstem—brain cancer	0.000169	0.00403	CbGeAlD
Tamoxifen—CYP2B6—gonad—brain cancer	0.000168	0.00402	CbGeAlD
Tamoxifen—Alopecia—Carmustine—brain cancer	0.000167	0.00158	CcSEcCtD
Tamoxifen—CYP1B1—central nervous system—brain cancer	0.000167	0.00398	CbGeAlD
Tamoxifen—Oedema—Hydroxyurea—brain cancer	0.000166	0.00157	CcSEcCtD
Tamoxifen—Infection—Hydroxyurea—brain cancer	0.000165	0.00156	CcSEcCtD
Tamoxifen—Erythema—Carmustine—brain cancer	0.000165	0.00156	CcSEcCtD
Tamoxifen—Pneumonia—Etoposide—brain cancer	0.000164	0.00155	CcSEcCtD
Tamoxifen—CYP1B1—cerebellum—brain cancer	0.000163	0.00389	CbGeAlD
Tamoxifen—Thrombocytopenia—Hydroxyurea—brain cancer	0.000163	0.00154	CcSEcCtD
Tamoxifen—CYP2C19—endocrine gland—brain cancer	0.000162	0.00388	CbGeAlD
Tamoxifen—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000161	0.00153	CcSEcCtD
Tamoxifen—Alopecia—Temozolomide—brain cancer	0.000161	0.00153	CcSEcCtD
Tamoxifen—Acute coronary syndrome—Etoposide—brain cancer	0.000161	0.00152	CcSEcCtD
Tamoxifen—Myocardial infarction—Etoposide—brain cancer	0.00016	0.00151	CcSEcCtD
Tamoxifen—Back pain—Carmustine—brain cancer	0.000159	0.00151	CcSEcCtD
Tamoxifen—Erythema—Temozolomide—brain cancer	0.000159	0.00151	CcSEcCtD
Tamoxifen—Anorexia—Hydroxyurea—brain cancer	0.000158	0.0015	CcSEcCtD
Tamoxifen—Hypersensitivity—Procarbazine—brain cancer	0.000158	0.0015	CcSEcCtD
Tamoxifen—ABCG2—midbrain—brain cancer	0.000157	0.00375	CbGeAlD
Tamoxifen—Dysgeusia—Temozolomide—brain cancer	0.000156	0.00147	CcSEcCtD
Tamoxifen—ESR1—central nervous system—brain cancer	0.000155	0.0037	CbGeAlD
Tamoxifen—Asthenia—Procarbazine—brain cancer	0.000154	0.00146	CcSEcCtD
Tamoxifen—Back pain—Temozolomide—brain cancer	0.000154	0.00146	CcSEcCtD
Tamoxifen—ABCG2—spinal cord—brain cancer	0.000153	0.00365	CbGeAlD
Tamoxifen—Promazine—CYP2C9—brain cancer	0.000152	0.0606	CrCbGaD
Tamoxifen—Anaemia—Carmustine—brain cancer	0.000152	0.00144	CcSEcCtD
Tamoxifen—Pruritus—Procarbazine—brain cancer	0.000152	0.00144	CcSEcCtD
Tamoxifen—ESR1—cerebellum—brain cancer	0.000151	0.00362	CbGeAlD
Tamoxifen—CYP2D6—telencephalon—brain cancer	0.00015	0.00358	CbGeAlD
Tamoxifen—CYP2E1—medulla oblongata—brain cancer	0.000148	0.00355	CbGeAlD
Tamoxifen—Dyspnoea—Hydroxyurea—brain cancer	0.000148	0.0014	CcSEcCtD
Tamoxifen—Leukopenia—Carmustine—brain cancer	0.000147	0.00139	CcSEcCtD
Tamoxifen—Anaemia—Temozolomide—brain cancer	0.000147	0.00139	CcSEcCtD
Tamoxifen—Diarrhoea—Procarbazine—brain cancer	0.000147	0.00139	CcSEcCtD
Tamoxifen—Dyspepsia—Hydroxyurea—brain cancer	0.000146	0.00138	CcSEcCtD
Tamoxifen—Hypoaesthesia—Etoposide—brain cancer	0.000145	0.00138	CcSEcCtD
Tamoxifen—Angioedema—Temozolomide—brain cancer	0.000145	0.00138	CcSEcCtD
Tamoxifen—Decreased appetite—Hydroxyurea—brain cancer	0.000144	0.00137	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000143	0.00136	CcSEcCtD
Tamoxifen—Fatigue—Hydroxyurea—brain cancer	0.000143	0.00136	CcSEcCtD
Tamoxifen—Leukopenia—Temozolomide—brain cancer	0.000142	0.00135	CcSEcCtD
Tamoxifen—Hypertension—Carmustine—brain cancer	0.000142	0.00135	CcSEcCtD
Tamoxifen—Pain—Hydroxyurea—brain cancer	0.000142	0.00135	CcSEcCtD
Tamoxifen—Constipation—Hydroxyurea—brain cancer	0.000142	0.00135	CcSEcCtD
Tamoxifen—Dizziness—Procarbazine—brain cancer	0.000142	0.00134	CcSEcCtD
Tamoxifen—CYP2C8—endocrine gland—brain cancer	0.000142	0.00338	CbGeAlD
Tamoxifen—CYP19A1—brain—brain cancer	0.000141	0.00338	CbGeAlD
Tamoxifen—Myalgia—Carmustine—brain cancer	0.00014	0.00133	CcSEcCtD
Tamoxifen—Chest pain—Carmustine—brain cancer	0.00014	0.00133	CcSEcCtD
Tamoxifen—Anxiety—Carmustine—brain cancer	0.00014	0.00132	CcSEcCtD
Tamoxifen—SIGMAR1—brain—brain cancer	0.000139	0.00332	CbGeAlD
Tamoxifen—Cough—Temozolomide—brain cancer	0.000139	0.00131	CcSEcCtD
Tamoxifen—Erythema multiforme—Etoposide—brain cancer	0.000138	0.00131	CcSEcCtD
Tamoxifen—Hypertension—Temozolomide—brain cancer	0.000137	0.0013	CcSEcCtD
Tamoxifen—Vomiting—Procarbazine—brain cancer	0.000137	0.00129	CcSEcCtD
Tamoxifen—Flushing—Etoposide—brain cancer	0.000136	0.00128	CcSEcCtD
Tamoxifen—Myalgia—Temozolomide—brain cancer	0.000135	0.00128	CcSEcCtD
Tamoxifen—Arthralgia—Temozolomide—brain cancer	0.000135	0.00128	CcSEcCtD
Tamoxifen—Rash—Procarbazine—brain cancer	0.000135	0.00128	CcSEcCtD
Tamoxifen—Dermatitis—Procarbazine—brain cancer	0.000135	0.00128	CcSEcCtD
Tamoxifen—Anxiety—Temozolomide—brain cancer	0.000135	0.00128	CcSEcCtD
Tamoxifen—Headache—Procarbazine—brain cancer	0.000135	0.00127	CcSEcCtD
Tamoxifen—Oedema—Carmustine—brain cancer	0.000134	0.00127	CcSEcCtD
Tamoxifen—Discomfort—Temozolomide—brain cancer	0.000134	0.00127	CcSEcCtD
Tamoxifen—Infection—Carmustine—brain cancer	0.000133	0.00126	CcSEcCtD
Tamoxifen—CYP1A2—endocrine gland—brain cancer	0.000133	0.00317	CbGeAlD
Tamoxifen—Dry mouth—Temozolomide—brain cancer	0.000132	0.00125	CcSEcCtD
Tamoxifen—CYP2E1—spinal cord—brain cancer	0.000132	0.00316	CbGeAlD
Tamoxifen—CYP1B1—brain—brain cancer	0.000132	0.00316	CbGeAlD
Tamoxifen—Thrombocytopenia—Carmustine—brain cancer	0.000132	0.00125	CcSEcCtD
Tamoxifen—CYP1A1—endocrine gland—brain cancer	0.000131	0.00312	CbGeAlD
Tamoxifen—Oedema—Temozolomide—brain cancer	0.00013	0.00123	CcSEcCtD
Tamoxifen—Alopecia—Etoposide—brain cancer	0.000129	0.00122	CcSEcCtD
Tamoxifen—CYP1A1—head—brain cancer	0.000129	0.00308	CbGeAlD
Tamoxifen—Infection—Temozolomide—brain cancer	0.000129	0.00122	CcSEcCtD
Tamoxifen—Anorexia—Carmustine—brain cancer	0.000128	0.00121	CcSEcCtD
Tamoxifen—CYP3A5—endocrine gland—brain cancer	0.000128	0.00305	CbGeAlD
Tamoxifen—Nausea—Procarbazine—brain cancer	0.000128	0.00121	CcSEcCtD
Tamoxifen—Thrombocytopenia—Temozolomide—brain cancer	0.000127	0.0012	CcSEcCtD
Tamoxifen—CYP2B6—endocrine gland—brain cancer	0.000127	0.00304	CbGeAlD
Tamoxifen—CYP2C9—endocrine gland—brain cancer	0.000126	0.00301	CbGeAlD
Tamoxifen—Hyperhidrosis—Temozolomide—brain cancer	0.000126	0.00119	CcSEcCtD
Tamoxifen—CYP2B6—head—brain cancer	0.000125	0.003	CbGeAlD
Tamoxifen—Dysgeusia—Etoposide—brain cancer	0.000125	0.00118	CcSEcCtD
Tamoxifen—Anorexia—Temozolomide—brain cancer	0.000124	0.00117	CcSEcCtD
Tamoxifen—Back pain—Etoposide—brain cancer	0.000123	0.00117	CcSEcCtD
Tamoxifen—ESR1—brain—brain cancer	0.000123	0.00294	CbGeAlD
Tamoxifen—Hypersensitivity—Hydroxyurea—brain cancer	0.000122	0.00116	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Carmustine—brain cancer	0.000122	0.00116	CcSEcCtD
Tamoxifen—Muscle spasms—Etoposide—brain cancer	0.000122	0.00116	CcSEcCtD
Tamoxifen—Insomnia—Carmustine—brain cancer	0.000122	0.00115	CcSEcCtD
Tamoxifen—ABCG2—cerebellum—brain cancer	0.000121	0.0029	CbGeAlD
Tamoxifen—Paraesthesia—Carmustine—brain cancer	0.000121	0.00114	CcSEcCtD
Tamoxifen—Dyspnoea—Carmustine—brain cancer	0.00012	0.00113	CcSEcCtD
Tamoxifen—Asthenia—Hydroxyurea—brain cancer	0.000119	0.00113	CcSEcCtD
Tamoxifen—CYP2E1—endocrine gland—brain cancer	0.000119	0.00285	CbGeAlD
Tamoxifen—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000118	0.00112	CcSEcCtD
Tamoxifen—CYP1A1—central nervous system—brain cancer	0.000118	0.00281	CbGeAlD
Tamoxifen—CYP2E1—head—brain cancer	0.000118	0.00281	CbGeAlD
Tamoxifen—Anaemia—Etoposide—brain cancer	0.000118	0.00111	CcSEcCtD
Tamoxifen—Insomnia—Temozolomide—brain cancer	0.000117	0.00111	CcSEcCtD
Tamoxifen—Decreased appetite—Carmustine—brain cancer	0.000117	0.00111	CcSEcCtD
Tamoxifen—Paraesthesia—Temozolomide—brain cancer	0.000117	0.0011	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Carmustine—brain cancer	0.000116	0.0011	CcSEcCtD
Tamoxifen—Dyspnoea—Temozolomide—brain cancer	0.000116	0.0011	CcSEcCtD
Tamoxifen—Pain—Carmustine—brain cancer	0.000115	0.00109	CcSEcCtD
Tamoxifen—Constipation—Carmustine—brain cancer	0.000115	0.00109	CcSEcCtD
Tamoxifen—CYP2B6—central nervous system—brain cancer	0.000114	0.00274	CbGeAlD
Tamoxifen—Dyspepsia—Temozolomide—brain cancer	0.000114	0.00108	CcSEcCtD
Tamoxifen—Leukopenia—Etoposide—brain cancer	0.000114	0.00108	CcSEcCtD
Tamoxifen—Diarrhoea—Hydroxyurea—brain cancer	0.000114	0.00108	CcSEcCtD
Tamoxifen—Decreased appetite—Temozolomide—brain cancer	0.000113	0.00107	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Temozolomide—brain cancer	0.000112	0.00106	CcSEcCtD
Tamoxifen—Fatigue—Temozolomide—brain cancer	0.000112	0.00106	CcSEcCtD
Tamoxifen—Cough—Etoposide—brain cancer	0.000111	0.00105	CcSEcCtD
Tamoxifen—Constipation—Temozolomide—brain cancer	0.000111	0.00105	CcSEcCtD
Tamoxifen—Pain—Temozolomide—brain cancer	0.000111	0.00105	CcSEcCtD
Tamoxifen—Hypertension—Etoposide—brain cancer	0.00011	0.00104	CcSEcCtD
Tamoxifen—Dizziness—Hydroxyurea—brain cancer	0.00011	0.00104	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Carmustine—brain cancer	0.00011	0.00104	CcSEcCtD
Tamoxifen—Chest pain—Etoposide—brain cancer	0.000108	0.00103	CcSEcCtD
Tamoxifen—ABCB1—telencephalon—brain cancer	0.000108	0.00257	CbGeAlD
Tamoxifen—CYP2E1—central nervous system—brain cancer	0.000107	0.00257	CbGeAlD
Tamoxifen—Discomfort—Etoposide—brain cancer	0.000107	0.00101	CcSEcCtD
Tamoxifen—Abdominal pain—Carmustine—brain cancer	0.000106	0.00101	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Temozolomide—brain cancer	0.000106	0.001	CcSEcCtD
Tamoxifen—Vomiting—Hydroxyurea—brain cancer	0.000106	0.001	CcSEcCtD
Tamoxifen—CYP2E1—cerebellum—brain cancer	0.000105	0.00251	CbGeAlD
Tamoxifen—Rash—Hydroxyurea—brain cancer	0.000105	0.000992	CcSEcCtD
Tamoxifen—Dermatitis—Hydroxyurea—brain cancer	0.000105	0.000991	CcSEcCtD
Tamoxifen—Headache—Hydroxyurea—brain cancer	0.000104	0.000986	CcSEcCtD
Tamoxifen—Infection—Etoposide—brain cancer	0.000103	0.000977	CcSEcCtD
Tamoxifen—Urticaria—Temozolomide—brain cancer	0.000103	0.000976	CcSEcCtD
Tamoxifen—Abdominal pain—Temozolomide—brain cancer	0.000103	0.000972	CcSEcCtD
Tamoxifen—Thrombocytopenia—Etoposide—brain cancer	0.000102	0.000963	CcSEcCtD
Tamoxifen—CYP2C8—brain—brain cancer	0.000101	0.00242	CbGeAlD
Tamoxifen—Hyperhidrosis—Etoposide—brain cancer	0.0001	0.000951	CcSEcCtD
Tamoxifen—Anorexia—Etoposide—brain cancer	9.9e-05	0.000937	CcSEcCtD
Tamoxifen—Hypersensitivity—Carmustine—brain cancer	9.9e-05	0.000937	CcSEcCtD
Tamoxifen—Nausea—Hydroxyurea—brain cancer	9.87e-05	0.000934	CcSEcCtD
Tamoxifen—ABCG2—brain—brain cancer	9.85e-05	0.00235	CbGeAlD
Tamoxifen—Asthenia—Carmustine—brain cancer	9.64e-05	0.000912	CcSEcCtD
Tamoxifen—CYP3A4—endocrine gland—brain cancer	9.59e-05	0.00229	CbGeAlD
Tamoxifen—Hypersensitivity—Temozolomide—brain cancer	9.56e-05	0.000905	CcSEcCtD
Tamoxifen—CYP2D6—endocrine gland—brain cancer	9.44e-05	0.00226	CbGeAlD
Tamoxifen—CYP1A1—brain—brain cancer	9.35e-05	0.00223	CbGeAlD
Tamoxifen—Paraesthesia—Etoposide—brain cancer	9.33e-05	0.000883	CcSEcCtD
Tamoxifen—CYP2D6—head—brain cancer	9.32e-05	0.00223	CbGeAlD
Tamoxifen—Asthenia—Temozolomide—brain cancer	9.31e-05	0.000882	CcSEcCtD
Tamoxifen—Dyspnoea—Etoposide—brain cancer	9.26e-05	0.000877	CcSEcCtD
Tamoxifen—Diarrhoea—Carmustine—brain cancer	9.19e-05	0.00087	CcSEcCtD
Tamoxifen—Pruritus—Temozolomide—brain cancer	9.19e-05	0.00087	CcSEcCtD
Tamoxifen—CYP2B6—brain—brain cancer	9.09e-05	0.00217	CbGeAlD
Tamoxifen—Decreased appetite—Etoposide—brain cancer	9.03e-05	0.000855	CcSEcCtD
Tamoxifen—ABCB1—gonad—brain cancer	8.98e-05	0.00215	CbGeAlD
Tamoxifen—Gastrointestinal disorder—Etoposide—brain cancer	8.97e-05	0.000849	CcSEcCtD
Tamoxifen—Fatigue—Etoposide—brain cancer	8.96e-05	0.000848	CcSEcCtD
Tamoxifen—Dizziness—Carmustine—brain cancer	8.88e-05	0.000841	CcSEcCtD
Tamoxifen—Pain—Etoposide—brain cancer	8.88e-05	0.000841	CcSEcCtD
Tamoxifen—Constipation—Etoposide—brain cancer	8.88e-05	0.000841	CcSEcCtD
Tamoxifen—Diarrhoea—Temozolomide—brain cancer	8.88e-05	0.000841	CcSEcCtD
Tamoxifen—ABCB1—pituitary gland—brain cancer	8.76e-05	0.00209	CbGeAlD
Tamoxifen—CYP3A4—central nervous system—brain cancer	8.64e-05	0.00207	CbGeAlD
Tamoxifen—Dizziness—Temozolomide—brain cancer	8.59e-05	0.000813	CcSEcCtD
Tamoxifen—Vomiting—Carmustine—brain cancer	8.54e-05	0.000809	CcSEcCtD
Tamoxifen—CYP2E1—brain—brain cancer	8.53e-05	0.00204	CbGeAlD
Tamoxifen—CYP2D6—central nervous system—brain cancer	8.5e-05	0.00203	CbGeAlD
Tamoxifen—Gastrointestinal pain—Etoposide—brain cancer	8.49e-05	0.000804	CcSEcCtD
Tamoxifen—Rash—Carmustine—brain cancer	8.47e-05	0.000802	CcSEcCtD
Tamoxifen—Dermatitis—Carmustine—brain cancer	8.46e-05	0.000801	CcSEcCtD
Tamoxifen—ABCB1—medulla oblongata—brain cancer	8.46e-05	0.00202	CbGeAlD
Tamoxifen—Headache—Carmustine—brain cancer	8.42e-05	0.000797	CcSEcCtD
Tamoxifen—CYP2D6—cerebellum—brain cancer	8.31e-05	0.00199	CbGeAlD
Tamoxifen—Vomiting—Temozolomide—brain cancer	8.25e-05	0.000781	CcSEcCtD
Tamoxifen—Urticaria—Etoposide—brain cancer	8.25e-05	0.000781	CcSEcCtD
Tamoxifen—Abdominal pain—Etoposide—brain cancer	8.21e-05	0.000777	CcSEcCtD
Tamoxifen—Rash—Temozolomide—brain cancer	8.19e-05	0.000775	CcSEcCtD
Tamoxifen—Dermatitis—Temozolomide—brain cancer	8.18e-05	0.000774	CcSEcCtD
Tamoxifen—Headache—Temozolomide—brain cancer	8.13e-05	0.00077	CcSEcCtD
Tamoxifen—Nausea—Carmustine—brain cancer	7.98e-05	0.000755	CcSEcCtD
Tamoxifen—ABCB1—midbrain—brain cancer	7.73e-05	0.00185	CbGeAlD
Tamoxifen—Nausea—Temozolomide—brain cancer	7.71e-05	0.00073	CcSEcCtD
Tamoxifen—Hypersensitivity—Etoposide—brain cancer	7.65e-05	0.000725	CcSEcCtD
Tamoxifen—ABCB1—spinal cord—brain cancer	7.54e-05	0.0018	CbGeAlD
Tamoxifen—Asthenia—Etoposide—brain cancer	7.45e-05	0.000706	CcSEcCtD
Tamoxifen—Pruritus—Etoposide—brain cancer	7.35e-05	0.000696	CcSEcCtD
Tamoxifen—Diarrhoea—Etoposide—brain cancer	7.11e-05	0.000673	CcSEcCtD
Tamoxifen—Dizziness—Etoposide—brain cancer	6.87e-05	0.00065	CcSEcCtD
Tamoxifen—ABCB1—endocrine gland—brain cancer	6.79e-05	0.00162	CbGeAlD
Tamoxifen—CYP2D6—brain—brain cancer	6.75e-05	0.00161	CbGeAlD
Tamoxifen—ABCB1—head—brain cancer	6.7e-05	0.0016	CbGeAlD
Tamoxifen—Vomiting—Etoposide—brain cancer	6.61e-05	0.000625	CcSEcCtD
Tamoxifen—Rash—Etoposide—brain cancer	6.55e-05	0.00062	CcSEcCtD
Tamoxifen—Dermatitis—Etoposide—brain cancer	6.54e-05	0.00062	CcSEcCtD
Tamoxifen—Headache—Etoposide—brain cancer	6.51e-05	0.000616	CcSEcCtD
Tamoxifen—Nausea—Etoposide—brain cancer	6.17e-05	0.000584	CcSEcCtD
Tamoxifen—ABCB1—central nervous system—brain cancer	6.12e-05	0.00146	CbGeAlD
Tamoxifen—ABCB1—cerebellum—brain cancer	5.98e-05	0.00143	CbGeAlD
Tamoxifen—ABCB1—brain—brain cancer	4.86e-05	0.00116	CbGeAlD
Tamoxifen—ABCB1—Allograft Rejection—PDGFRA—brain cancer	3.56e-05	0.00051	CbGpPWpGaD
Tamoxifen—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	3.52e-05	0.000505	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	3.5e-05	0.000502	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—IRS2—brain cancer	3.49e-05	0.000502	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—ENO2—brain cancer	3.49e-05	0.000501	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	3.46e-05	0.000497	CbGpPWpGaD
Tamoxifen—CYP3A4—Biological oxidations—CYP2C9—brain cancer	3.44e-05	0.000493	CbGpPWpGaD
Tamoxifen—ESR1—Validated nuclear estrogen receptor alpha network—MYC—brain cancer	3.39e-05	0.000487	CbGpPWpGaD
Tamoxifen—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	3.39e-05	0.000487	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.35e-05	0.00048	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—ESR2—brain cancer	3.34e-05	0.00048	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.32e-05	0.000476	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.31e-05	0.000475	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—CDK4—brain cancer	3.3e-05	0.000473	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—ENO2—brain cancer	3.25e-05	0.000466	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of Telomerase—MYC—brain cancer	3.23e-05	0.000464	CbGpPWpGaD
Tamoxifen—ESR1—Leptin signaling pathway—STAT3—brain cancer	3.22e-05	0.000462	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.18e-05	0.000457	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.18e-05	0.000457	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—NOTCH2—brain cancer	3.17e-05	0.000454	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of Telomerase—EGFR—brain cancer	3.16e-05	0.000454	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	3.16e-05	0.000454	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—IDH1—brain cancer	3.16e-05	0.000454	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—MYC—brain cancer	3.16e-05	0.000453	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—BSG—brain cancer	3.08e-05	0.000442	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3.05e-05	0.000438	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	2.97e-05	0.000426	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	2.93e-05	0.00042	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	2.86e-05	0.000411	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	2.86e-05	0.000411	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	2.81e-05	0.000403	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	2.81e-05	0.000403	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.81e-05	0.000403	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.74e-05	0.000394	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.73e-05	0.000392	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—SIRT1—brain cancer	2.69e-05	0.000386	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.68e-05	0.000385	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—CYP2C9—brain cancer	2.67e-05	0.000383	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	2.65e-05	0.00038	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—IDH1—brain cancer	2.65e-05	0.00038	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—OR14C36—brain cancer	2.63e-05	0.000377	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—OR4C12—brain cancer	2.63e-05	0.000377	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—TP53—brain cancer	2.59e-05	0.000372	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.57e-05	0.000369	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—ENO2—brain cancer	2.5e-05	0.000358	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.46e-05	0.000353	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	2.46e-05	0.000353	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—TRPC6—brain cancer	2.41e-05	0.000347	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—ERBB2—brain cancer	2.4e-05	0.000344	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	2.39e-05	0.000343	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—CCND1—brain cancer	2.38e-05	0.000341	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	2.37e-05	0.000341	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—DNMT1—brain cancer	2.37e-05	0.00034	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	2.35e-05	0.000338	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.3e-05	0.000331	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—BSG—brain cancer	2.27e-05	0.000326	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—DTX2—brain cancer	2.23e-05	0.00032	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—ESR2—brain cancer	2.23e-05	0.00032	CbGpPWpGaD
Tamoxifen—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	2.22e-05	0.000319	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.19e-05	0.000315	CbGpPWpGaD
Tamoxifen—ESRRA—Generic Transcription Pathway—MYC—brain cancer	2.19e-05	0.000314	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—CCND1—brain cancer	2.13e-05	0.000306	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—NOTCH2—brain cancer	2.11e-05	0.000303	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	2.11e-05	0.000303	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	2.1e-05	0.000301	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—ENO2—brain cancer	2.09e-05	0.0003	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	2.07e-05	0.000298	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	2.03e-05	0.000291	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—NOTCH2—brain cancer	2.01e-05	0.000289	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—CYP2C9—brain cancer	2.01e-05	0.000289	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2e-05	0.000287	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—PIK3CG—brain cancer	1.97e-05	0.000282	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.96e-05	0.000282	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—IDH1—brain cancer	1.95e-05	0.00028	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	1.95e-05	0.00028	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—IL2—brain cancer	1.94e-05	0.000278	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—CYP2C9—brain cancer	1.94e-05	0.000278	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—PIK3CG—brain cancer	1.93e-05	0.000277	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	1.91e-05	0.000274	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—MYC—brain cancer	1.91e-05	0.000274	CbGpPWpGaD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	1.9e-05	0.000273	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	1.89e-05	0.000271	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	1.87e-05	0.000268	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—EGFR—brain cancer	1.87e-05	0.000268	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—PIK3CG—brain cancer	1.86e-05	0.000268	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	1.86e-05	0.000266	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	1.83e-05	0.000262	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	1.83e-05	0.000262	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.8e-05	0.000258	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—CYP2C9—brain cancer	1.76e-05	0.000253	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.76e-05	0.000253	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	1.75e-05	0.000252	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—CYP2C9—brain cancer	1.75e-05	0.000251	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.75e-05	0.000251	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—SIRT1—brain cancer	1.71e-05	0.000246	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—BSG—brain cancer	1.71e-05	0.000246	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.71e-05	0.000245	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—MYC—brain cancer	1.71e-05	0.000245	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTCH2—brain cancer	1.69e-05	0.000243	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	1.67e-05	0.00024	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—EGFR—brain cancer	1.67e-05	0.00024	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—EGFR—brain cancer	1.66e-05	0.000238	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—BSG—brain cancer	1.65e-05	0.000237	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—VEGFA—brain cancer	1.65e-05	0.000237	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HES5—brain cancer	1.64e-05	0.000235	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.6e-05	0.00023	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CYP2C9—brain cancer	1.6e-05	0.00023	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—PIK3CG—brain cancer	1.6e-05	0.00023	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—STRADA—brain cancer	1.59e-05	0.000228	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.59e-05	0.000228	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—TP53—brain cancer	1.57e-05	0.000225	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—ENO2—brain cancer	1.54e-05	0.000221	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.54e-05	0.000221	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—BSG—brain cancer	1.5e-05	0.000215	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—PIK3CG—brain cancer	1.49e-05	0.000214	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—BSG—brain cancer	1.49e-05	0.000213	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—IDH1—brain cancer	1.47e-05	0.000211	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.46e-05	0.00021	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.45e-05	0.000207	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—IDH1—brain cancer	1.42e-05	0.000204	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.41e-05	0.000203	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—TP53—brain cancer	1.4e-05	0.000201	CbGpPWpGaD
Tamoxifen—ESR2—Generic Transcription Pathway—MYC—brain cancer	1.39e-05	0.0002	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.38e-05	0.000199	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—BSG—brain cancer	1.36e-05	0.000196	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.36e-05	0.000195	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ABR—brain cancer	1.33e-05	0.000191	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CYP2C9—brain cancer	1.29e-05	0.000186	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—IDH1—brain cancer	1.29e-05	0.000185	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—GLI2—brain cancer	1.28e-05	0.000184	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—IDH1—brain cancer	1.28e-05	0.000184	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CYP2C9—brain cancer	1.27e-05	0.000182	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CYP2C9—brain cancer	1.26e-05	0.000181	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.25e-05	0.000179	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—GLI1—brain cancer	1.21e-05	0.000173	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.2e-05	0.000172	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—DNMT1—brain cancer	1.19e-05	0.000171	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CYP2C9—brain cancer	1.19e-05	0.000171	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—IDH1—brain cancer	1.17e-05	0.000168	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—ENO2—brain cancer	1.16e-05	0.000167	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.16e-05	0.000167	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.15e-05	0.000166	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—PIK3CG—brain cancer	1.15e-05	0.000164	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SUFU—brain cancer	1.14e-05	0.000164	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.14e-05	0.000163	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—ENO2—brain cancer	1.12e-05	0.000161	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—GFAP—brain cancer	1.1e-05	0.000158	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—BSG—brain cancer	1.1e-05	0.000158	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CYP2C9—brain cancer	1.1e-05	0.000157	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—BSG—brain cancer	1.08e-05	0.000155	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—BSG—brain cancer	1.08e-05	0.000154	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—ESR2—brain cancer	1.07e-05	0.000154	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.06e-05	0.000152	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—MYC—brain cancer	1.05e-05	0.000151	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HEY1—brain cancer	1.05e-05	0.00015	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—DLL1—brain cancer	1.02e-05	0.000147	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ENO2—brain cancer	1.02e-05	0.000146	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—NOTCH2—brain cancer	1.02e-05	0.000146	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—BSG—brain cancer	1.02e-05	0.000146	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ENO2—brain cancer	1.01e-05	0.000145	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CYP2C9—brain cancer	9.78e-06	0.00014	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PIK3CG—brain cancer	9.6e-06	0.000138	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP2C9—brain cancer	9.54e-06	0.000137	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—IDH1—brain cancer	9.46e-06	0.000136	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	9.33e-06	0.000134	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—BSG—brain cancer	9.31e-06	0.000134	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ENO2—brain cancer	9.27e-06	0.000133	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—IDH1—brain cancer	9.26e-06	0.000133	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—IDH1—brain cancer	9.25e-06	0.000133	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	9.24e-06	0.000133	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYP2C9—brain cancer	8.99e-06	0.000129	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—IDH1—brain cancer	8.73e-06	0.000125	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SHH—brain cancer	8.72e-06	0.000125	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—SIRT1—brain cancer	8.64e-06	0.000124	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TRPC6—brain cancer	8.4e-06	0.000121	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—BSG—brain cancer	8.31e-06	0.000119	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTCH1—brain cancer	8.26e-06	0.000119	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SMO—brain cancer	8.26e-06	0.000119	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	8.14e-06	0.000117	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—BSG—brain cancer	8.11e-06	0.000116	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—IDH1—brain cancer	8.01e-06	0.000115	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—BSG—brain cancer	7.64e-06	0.00011	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP2C9—brain cancer	7.62e-06	0.000109	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—BSG—brain cancer	7.58e-06	0.000109	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	7.49e-06	0.000107	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ENO2—brain cancer	7.48e-06	0.000107	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ENO2—brain cancer	7.32e-06	0.000105	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	7.32e-06	0.000105	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ENO2—brain cancer	7.31e-06	0.000105	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—IDH1—brain cancer	7.15e-06	0.000103	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.11e-06	0.000102	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PIK3CG—brain cancer	7.08e-06	0.000102	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—MYC—brain cancer	7.03e-06	0.000101	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—IDH1—brain cancer	6.98e-06	0.0001	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ENO2—brain cancer	6.9e-06	9.91e-05	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—MYC—brain cancer	6.71e-06	9.63e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NOTCH2—brain cancer	6.6e-06	9.48e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—IDH1—brain cancer	6.57e-06	9.44e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.52e-06	9.36e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—IDH1—brain cancer	6.52e-06	9.35e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—BSG—brain cancer	6.48e-06	9.3e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ENO2—brain cancer	6.33e-06	9.09e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VAV1—brain cancer	6.3e-06	9.04e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	6.15e-06	8.82e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP2C9—brain cancer	5.88e-06	8.44e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.82e-06	8.35e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ENO2—brain cancer	5.65e-06	8.11e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—IDH1—brain cancer	5.57e-06	7.99e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ENO2—brain cancer	5.51e-06	7.92e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HES1—brain cancer	5.42e-06	7.77e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PIK3CG—brain cancer	5.34e-06	7.67e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.31e-06	7.62e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ENO2—brain cancer	5.2e-06	7.46e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PDGFRA—brain cancer	5.16e-06	7.4e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ENO2—brain cancer	5.15e-06	7.39e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CG—brain cancer	5.14e-06	7.38e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SPP1—brain cancer	5.01e-06	7.18e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—BSG—brain cancer	5e-06	7.17e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CG—brain cancer	4.68e-06	6.72e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CG—brain cancer	4.64e-06	6.66e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.53e-06	6.51e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IRS2—brain cancer	4.53e-06	6.5e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ENO2—brain cancer	4.4e-06	6.32e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—IDH1—brain cancer	4.3e-06	6.17e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CG—brain cancer	4.25e-06	6.1e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CG—brain cancer	4e-06	5.74e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—APC—brain cancer	4e-06	5.74e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CG—brain cancer	3.43e-06	4.92e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ENO2—brain cancer	3.4e-06	4.88e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MYC—brain cancer	3.38e-06	4.86e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CG—brain cancer	3.36e-06	4.82e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CG—brain cancer	3.35e-06	4.81e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CG—brain cancer	3.17e-06	4.55e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RELA—brain cancer	3.12e-06	4.48e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ERBB2—brain cancer	3.1e-06	4.46e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CG—brain cancer	2.9e-06	4.17e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL2—brain cancer	2.81e-06	4.04e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCND1—brain cancer	2.74e-06	3.94e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CTNNB1—brain cancer	2.72e-06	3.9e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CG—brain cancer	2.59e-06	3.72e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CG—brain cancer	2.53e-06	3.63e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—brain cancer	2.39e-06	3.43e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CG—brain cancer	2.38e-06	3.42e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—STAT3—brain cancer	2.37e-06	3.4e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CG—brain cancer	2.36e-06	3.39e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MYC—brain cancer	2.2e-06	3.16e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EGFR—brain cancer	2.15e-06	3.09e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CG—brain cancer	2.02e-06	2.9e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—brain cancer	1.81e-06	2.59e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CG—brain cancer	1.56e-06	2.24e-05	CbGpPWpGaD
